Author:
KNIGHT C.,DANØ A. M.,KENNEDY-MARTIN T.
Subject
Genetics (clinical),Hematology,General Medicine
Reference20 articles.
1. A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors;Knight;Haemophilia,2009
2. A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors;Hay;Haemophilia,2009
3. Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors;Knight;Haemophilia,2003
4. Cost-effectiveness of FEIBA vs. NovoSeven as initial therapy for the treatment of mild-to-moderate bleeds in hemophilia patients with inhibitors. Abstracts of the XXVIth International Congress of The World Federation of Hemophilia;Chung;Haemophilia,2004
5. Health-economic analysis of alternative bypassing agents in haemophilia complicated by an inhibitor - the FEIBA® NovoSeven® Comparative Study (FENOC);Carlsson;Blood,2006